APAC's Volume Share and Margins in the Contract Research Organisation Market Set to Increase, Finds Frost & Sullivan

Growth in health economics and outcomes research segments will be strong

Nov 24, 2015, 22:06 ET from Frost & Sullivan

KUALA LUMPUR, Malaysia, Nov. 24, 2015 /PRNewswire/ -- Asia-Pacific (APAC) holds the third-largest share of the global contract research organisation (CRO) market. The trend of outsourcing to low-cost locations is likely to result in lower margins but higher volume share for the region in the short term. With increased capacity and scale, however, margins in the CRO industry will improve.

New analysis from Frost & Sullivan, APAC Contract Research Organisation (CRO) Market (http://www.frost.com/sublib/display-report.do?id=P86A-01-00-00-00&src=PR), finds that the market earned revenues of US$3.47 billion in 2014 and estimates this to more than double to US$8.45 billion in 2019 at a robust compound annual growth rate of 19.5 percent.

APAC is experiencing tremendous growth in R&D spending due to increased globalisation of the pharmaceutical and biotechnology markets. CROs in the region are hugely benefitting from this trend.

"Health economics and outcomes research is becoming a crucial segment in the APAC CRO business," said Frost & Sullivan Healthcare Consultant Sanjeev Kumar. "Pricing pressures and regulatory restrictions are creating a demand for these services, which provide information on products and its potential and pave the way for market access."

However, outsourcing will remain limited among big pharmaceutical clients, who have in-house R&D and clinical drug testing facilities due to their high capacity and financial strength. This, along with the lack of intellectual property (IP) protection, will restrict CRO market development.

"Insufficient IP protection is a major concern among multinational companies (MNCs) that are looking to conduct trials in APAC," noted Kumar. "Even though regulations have improved significantly over the years, there are still some loopholes in terms of enforcement and sanctions, especially in countries such as China, where revelation of extensive information that MNCs consider proprietary is required."

Opportunities for CROs will nevertheless prevail in the APAC market. With the rapidly-expanding middle class population in the region changing their lifestyle due to more Western influence, the number of people suffering from similar diseases as those in developed countries is growing. Infectious diseases that are only prevalent in developing nations are also rising. Consequently, healthcare companies are faced with a more diverse set of ailments to address, making patient recruitment easier and the need for CROs stronger.

For more information on this study, please email Donna Jeremiah, Corporate Communications, at djeremiah@frost.com.

APAC Contract Research Organisation (CRO) Market is part of the Life Sciences (http://ww2.frost.com/research/industry/healthcare/life-sciences) Growth Partnership Service program. Frost & Sullivan's related studies include: Global CRO Market, Indonesia Healthcare Outlook, and New Technologies that will Impact the Global Pharmaceutical Packaging Industry. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

APAC Contract Research Organisation (CRO) Market 
P86A-52

Contact: 
Donna Jeremiah 
Corporate Communications – Asia Pacific 
P: +61 (02) 8247 8927 
F: +61 (02) 9252 8066 
E: djeremiah@frost.com

Carrie Low 
Corporate Communications – Asia Pacific 
P: +603 6204 5910 
F: +603 6201 7402 
E: carrie.low@frost.com

Melissa Tan 
Corporate Communications – Asia Pacific 
P: +65 6890 0926 
F: +65 6890 0999 
E: melissa.tan@frost.com

http://www.frost.com

 

SOURCE Frost & Sullivan



RELATED LINKS

http://www.frost.com